Advertisement
Advertisement
LUCD
Lucid Diagnostics Inc. Common Stock
0.92
USDSponsored
0.00
+0.46%
Jul 29, 15:59 UTC -4
Closed
After-Market
0.93
+0.01
+1.35%
LUCD Earnings Reports
Positive Surprise Ratio
LUCD beat 8 of 19 last estimates.
42%
Next Report
Date of Next Report
Aug 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.47M
/-$0.06
Implied change from Q1 26 (Revenue/ EPS)
+16.98%
/-64.71%
Implied change from Q2 25 (Revenue/ EPS)
+26.33%
/-25.00%
Lucid Diagnostics Inc. Common Stock earnings per share and revenue
On May 13, 2026, LUCD reported earnings of -0.17 USD per share (EPS) for Q1 26, missing the estimate of -0.08 USD, resulting in a -100.71% surprise. Revenue reached 1.26 million, compared to an expected 1.41 million, with a -10.96% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 8 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 1.47 million USD, implying an decrease of -64.71% EPS, and increase of 16.98% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Axogen, Inc. Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.12
Actual
$0.12
Surprise
-5.88%
Opko Health Inc.
Report Date
Jul 27, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.01
Surprise
+87.62%
Integra LifeSciences Holdings
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.49
Actual
$0.56
Surprise
+13.57%
Beta Bionics, Inc. Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$0.60
Actual
-$0.53
Surprise
+12.77%
Thermo Fisher Scientific, Inc.
Report Date
Jul 23, 2026 For Q2 26
Estimate
$5.76
Actual
$6.03
Surprise
+4.54%
Intuitive Surgical Inc.
Report Date
Jul 16, 2026 For Q2 26
Estimate
$2.55
Actual
$2.80
Surprise
+9.79%
Edwards Lifesciences Corp
Report Date
Jul 23, 2026 For Q2 26
Estimate
$0.76
Actual
$0.78
Surprise
+2.13%
IQVIA Holdings Inc.
Report Date
Jul 28, 2026 For Q2 26
Estimate
$3.06
Actual
$3.15
Surprise
+2.92%
Glaukos Corporation
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$0.22
Actual
-$0.14
Surprise
+38.52%
FAQ
What were Lucid Diagnostics Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Lucid Diagnostics Inc. Common Stock reported EPS of -$0.17, missing estimates by -100.71%, and revenue of $1.26M, -10.96% below expectations.
How did the market react to Lucid Diagnostics Inc. Common Stock's Q1 2026 earnings?
The stock price moved -- 0%, changed from $1.02 before the earnings release to $1.02 the day after.
When is Lucid Diagnostics Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 11, 2026.
What are the forecasts for Lucid Diagnostics Inc. Common Stock's next earnings report?
Based on 8
analysts, Lucid Diagnostics Inc. Common Stock is expected to report EPS of -$0.06 and revenue of $1.47M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement